White House Proposes Big Expansion of Medicare, Medicaid Coverage of Obesity Drugs
Amgen Posts Mid-stage Data for Weight Loss Therapy
Update: Market Chatter: Eli Lilly, Novo Nordisk Press Employers to Cover the Cost of Weight-Loss Drugs
Novo Nordisk's earnings in the first three quarters saw a significant increase of 76% year-on-year, with weight loss becoming a growth engine for novo-nordisk a/s.
This century-old pharmaceutical company is attracting the attention of global investors with its groundbreaking achievements in the field of obesity treatment.
"Norel" welcomes a heavyweight bullish news! It is rumored that weight loss drugs are expected to enter the US medical insurance system.
According to reports, the government led by usa President Biden is proposing a regulation that would require payment for weight loss drugs, potentially expanding access to these medications for millions of obese americans and creating a massive new medical bill for elected President Donald Trump.
Novo Nordisk Shares Higher on White House Plans to Extend Obesity Drug Coverage -- Market Talk
loading...
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}